Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q16981503> ?p ?o }
Showing triples 1 to 53 of
53
with 100 triples per page.
- Q16981503 subject Q13285751.
- Q16981503 subject Q15135464.
- Q16981503 subject Q6996300.
- Q16981503 subject Q6996306.
- Q16981503 subject Q6996388.
- Q16981503 subject Q6996496.
- Q16981503 subject Q6996516.
- Q16981503 subject Q6996759.
- Q16981503 abstract "FTC v. Actavis, Inc., 570 U.S. ___ (2013), was a United States Supreme Court case that questioned the relationship between patent law and antitrust law. The question at hand was whether it was illegal for brand-name manufacturers to use reverse payment settlements to keep would-be generic competitors out of the market, even if the brand-name drug company held a legal limited monopoly in the form of a patent. While the Court refused to declare that such settlements were presumptively illegal, it did rule 5-3 that the Federal Trade Commission (FTC) could not be prevented from bringing antitrust action against the defendants to try for the unlawfulness of the reverse payment settlement.".
- Q16981503 wikiPageExternalLink 12-416_m5n0.pdf.
- Q16981503 wikiPageExternalLink ftc-v-actavis-the-supreme-court-issues-a-reversal-on-reverse-payments.
- Q16981503 wikiPageExternalLink 12-416.html.
- Q16981503 wikiPageExternalLink 200212091.pdf.
- Q16981503 wikiPageExternalLink 0710060.
- Q16981503 wikiPageExternalLink 130926actavis.pdf.
- Q16981503 wikiPageExternalLink argument.
- Q16981503 wikiPageExternalLink opinion.
- Q16981503 wikiPageExternalLink federal-trade-commission-v-actavis-inc-2013.html.
- Q16981503 wikiPageWikiLink Q11201.
- Q16981503 wikiPageWikiLink Q13285751.
- Q16981503 wikiPageWikiLink Q1425088.
- Q16981503 wikiPageWikiLink Q15135464.
- Q16981503 wikiPageWikiLink Q204711.
- Q16981503 wikiPageWikiLink Q250446.
- Q16981503 wikiPageWikiLink Q253623.
- Q16981503 wikiPageWikiLink Q326498.
- Q16981503 wikiPageWikiLink Q3277149.
- Q16981503 wikiPageWikiLink Q343204.
- Q16981503 wikiPageWikiLink Q3736892.
- Q16981503 wikiPageWikiLink Q5308858.
- Q16981503 wikiPageWikiLink Q6996300.
- Q16981503 wikiPageWikiLink Q6996306.
- Q16981503 wikiPageWikiLink Q6996388.
- Q16981503 wikiPageWikiLink Q6996496.
- Q16981503 wikiPageWikiLink Q6996516.
- Q16981503 wikiPageWikiLink Q6996759.
- Q16981503 wikiPageWikiLink Q706184.
- Q16981503 wikiPageWikiLink Q7144498.
- Q16981503 wikiPageWikiLink Q7318253.
- Q16981503 wikiPageWikiLink Q786713.
- Q16981503 wikiPageWikiLink Q7889823.
- Q16981503 wikiPageWikiLink Q908639.
- Q16981503 fullname "Federal Trade Commission v. Actavis, Inc., et al.".
- Q16981503 type Case.
- Q16981503 type LegalCase.
- Q16981503 type SupremeCourtOfTheUnitedStatesCase.
- Q16981503 type UnitOfWork.
- Q16981503 type Situation.
- Q16981503 type Thing.
- Q16981503 type Q2334719.
- Q16981503 comment "FTC v. Actavis, Inc., 570 U.S. ___ (2013), was a United States Supreme Court case that questioned the relationship between patent law and antitrust law. The question at hand was whether it was illegal for brand-name manufacturers to use reverse payment settlements to keep would-be generic competitors out of the market, even if the brand-name drug company held a legal limited monopoly in the form of a patent.".
- Q16981503 label "FTC v. Actavis, Inc.".
- Q16981503 name "Federal Trade Commission v. Actavis, Inc., et al.".